157 related articles for article (PubMed ID: 6190203)
21. In vitro and in vivo antitumoral activity of free, and encapsulated taxol.
Bartoli MH; Boitard M; Fessi H; Beriel H; Devissaguet JP; Picot F; Puisieux F
J Microencapsul; 1990; 7(2):191-7. PubMed ID: 1970357
[TBL] [Abstract][Full Text] [Related]
22. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
Naujokaitis SA
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
[TBL] [Abstract][Full Text] [Related]
23. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
24. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
26. Multivesicular liposomes containing cytarabine for slow-release Sc administration.
Kim S; Howell SB
Cancer Treat Rep; 1987 May; 71(5):447-50. PubMed ID: 3567968
[TBL] [Abstract][Full Text] [Related]
27. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
Morin MJ; Bernacki RJ
Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042
[TBL] [Abstract][Full Text] [Related]
28. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
29. The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomes.
Supersaxo A; Rubas W; Hartmann HR; Schott H; Hengartner H; Schwendener RA
J Microencapsul; 1988; 5(1):1-11. PubMed ID: 2974073
[TBL] [Abstract][Full Text] [Related]
30. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
33. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
[TBL] [Abstract][Full Text] [Related]
35. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
[TBL] [Abstract][Full Text] [Related]
36. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
37. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
38. Liposomes as carriers of different new lipophilic antitumour drugs: a preliminary report.
Sampedro F; Partika J; Santalo P; Molins-Pujol AM; Bonal J; Perez-Soler R
J Microencapsul; 1994; 11(3):309-18. PubMed ID: 8064554
[TBL] [Abstract][Full Text] [Related]
39. Effect of lithium on the myelosuppressive and chemotherapeutic activities of vinblastine.
Cass CE; Turner AR; Selner M; Allalunis MJ; Tan TH
Cancer Res; 1981 Mar; 41(3):1000-5. PubMed ID: 7459846
[TBL] [Abstract][Full Text] [Related]
40. Relative enhancement by various liposomes of BCNU effectiveness against L-1210 leukemia in vivo.
Ritter C; Rutman RJ
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):123-31. PubMed ID: 7433763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
